Board approved re-appointment of Saurabh Bangur as Managing Director for five years effective October 1, 2026, subject to shareholder approval.
Bangur credited with steering company through operational transformation and spearheading Tissue Machine Project for product diversification.
Re-appointment follows Nomination and Remuneration Committee recommendation, with current term ending September 30, 2026.
Disclosure includes detailed profile highlighting Bangur's experience in operations, finance, and turnaround strategy.